Welcome to LookChem.com Sign In|Join Free
  • or
L-Tyrosine, N-[[(4R)-5,5-dimethyl-3-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]-4-thiazolidin yl]carbonyl]-, 1-methylethyl ester, dimethylcarbamate (ester) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

220545-48-2

Post Buying Request

220545-48-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

220545-48-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 220545-48-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,5,4 and 5 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 220545-48:
(8*2)+(7*2)+(6*0)+(5*5)+(4*4)+(3*5)+(2*4)+(1*8)=102
102 % 10 = 2
So 220545-48-2 is a valid CAS Registry Number.

220545-48-2Downstream Products

220545-48-2Relevant academic research and scientific papers

Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists

Huryn, Donna M.,Ashwell, Susan,Baudy, Reinhardt,Dressen, Darren B.,Gallaway, William,Grant, Francine S.,Konradi, Andrei,Ley, Robert W.,Petusky, Susan,Pleiss, Michael A.,Sarantakis, Dimitri,Semko, Christopher M.,Sherman, Mary M.,Tio, Cesar,Zhang, Lu

, p. 1651 - 1654 (2004)

A pro-drug strategy to identify orally efficacious VLA-4 antagonists is described. Potential pro-drugs were evaluated for their physical chemical characteristics and in vitro properties, including solubility, stability, permeability and plasma stability.

STEROID SPARING AGENTS AND METHODS OF USING SAME

-

Page/Page column 441-442, (2010/02/14)

This invention relates generally to the use of a steroid sparing agent for the preparation of a medicament for the treatment of inflammatory bowel diseases (IBD), asthma, multiple sclerosis (MS), rheumatoid arthritis (RA), graft versus host disease (GVHD), host versus graft disease, and various spondyloarthropathies, comprising administering a steroid sparing immunoglobulin or small molecule composition to a patient in need thereof. The invention also relates generally to combination therapies for the treatment of these conditions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 220545-48-2